As spatial biology technology continues its rapid advancement, it now offers unprecedented resolution, multiplexing capabilities, and reproducibility, driving major breakthroughs across numerous therapeutic areas and offering new insights into disease biology. Despite this progress, several key barriers still significantly limit the complete application of spatial biology within drug development workflows. Overcoming these fundamental challenges is essential for achieving widespread, successful adoption in both research settings and clinical translation.

The 3rd Spatial Biology for Drug Development Summit provides a dedicated forum for leading biopharma experts to directly address these hurdles. The intensive two-day agenda is structured to explore practical solutions to issues spanning critical areas such as data infrastructure, multi-omics integration, standardization, scalability, and translation into the clinic. This forum is designed to equip attendees with the latest data-driven strategies necessary not only to overcome current obstacles but also to maximize the value of spatial biology for deeper disease insights, robust target identification, and enhanced biomarker discovery.